Fredun Pharmaceuticals moves higher after foraying into large animal veterinary segment
Fredun Pharmaceuticals is currently trading at Rs 695.10, up by 21.30 points or 3.16% from its previous closing of Rs 673.80 on the BSE.
The scrip opened at Rs 675.00 and has touched a high and low of Rs 710.00 and Rs 675.00 respectively. So far 1933 shares were traded on the counter.
The BSE group 'X' stock of face value Rs 10 has touched a 52-week high of Rs 1024.00 on 07-May-2024 and a 52-week low of Rs 635.00 on 16-Jan-2025.
Last one week high and low of the scrip stood at Rs 710.00 and Rs 655.00 respectively. The current market cap of the company is Rs 327.68 crore.
The promoters holding in the company stood at 48.93%, while Institutions and Non-Institutions held 1.59% and 49.48% respectively.
Fredun Pharmaceuticals has forayed into the large animal veterinary segment, under the FREOSSI Large Animals brand with the launch of targeted products Freossi Tone+ and Freossi Power. FREOSSI has a strong & existing reputation in companion animal care, hence this will provide a foundation of trust and reliability when expanding into large animal products. These new products have scientific & clinical evidence and are developed with the expertise of veterinary professionals in animal health. They specifically are designed to address key health challenges faced by livestock owners including lactation issues, quality of milk, joint stiffness, and mobility concerns.
A scientifically formulated supplement, Freossi Tone+ supports higher milk yield & better milk quality, improved lactation cycles, and overall skeletal and muscular health. Enriched with Microcrystalline Hydroxyapatite Complex (MCHC), proteins, collagens, and a proprietary blend with evaluated ratios of herbal extracts, it is ideal for cows, buffaloes, goats, and horses. Freossi Power is designed to alleviate joint stiffness, lameness, and inflammation in large animals. Its active ingredients Microcrystalline Hydroxyapatite Complex (MCHC) including Glucosamine Sulphate USP and Methylsulfonylmethane (MSM), support joint health, flexibility, and endurance, making it ideal for horses, bulls, ponies, and cattle.
Fredun Pharmaceuticals is engaged in manufacturing of pharmaceutical products.
